Advent Pharma Limited is a front ranking exclusively dedicated manufacturer of Animal Health Care Products in Bangladesh. The company is dedicated to providing the best quality health care options for commercial animal producers by utilizing cutting edge machinery in developing a wide variety of health products to meet the growing demands of the fledgling sector. As a company, Advent Pharma is committed to guaranteeing high customer satisfaction and to consolidate itself as one of the trusted names in the Animal Health Care industry. Advent Pharma Ltd began its journey in 2007 and since then has been a pioneering presence in the industry due to the sophisticated machinery being employed by the company. The company and all its members believe that quality health care solutions for the veterinary sector should be a prerequisite in order to sustain and grow the economy at both local and national levels. To this end, Advent Pharma continues to uphold its values of high-quality products and exception quality assurance with a wide variety of products. This has led to Advent Pharma Ltd fast becoming a trusted name in the sector.


Advent Pharma Limited (APL) is a Pharmaceutical company which is engaged in manufacturing, importing and marketing of animal health care drugs, nutritional supplements and feed additives for livestock such as powder, bolus and liquid dosage forms. APL has earned a reputation as a successful animal health medicine manufacturer over the last few years.

Advent Pharma Limited was incorporated as a Private Limited Company on 25th January, 2007 and subsequently converted into a Public Limited Company on 7th May 2016 under Companies Act 1994 with the Registrar of Joint Stock Companies and Firms, Dhaka, Bangladesh under the Companies Act, 1994. The Certificate of Incorporation number is C-65459(2951)/2007.

The Company started its commercial operation on March 01, 2013.The Company gets consent for IPO (Initial Public Offering) as on January 11, 2018 from Bangladesh Securities and Exchange Commission. Accordingly the company listed with CSE (Chittagong Stock Exchange Ltd) as on March 28, 2018 and listed with DSE (Dhaka Stock Exchange Ltd) as on April 01, 2018. Advent Pharma Limited starts its trade from April 12, 2018 at DSE (Dhaka Stock Exchange Ltd) and CSE (Chittagong Stock Exchange Ltd).

Name of the Company : Advent Pharma Limited

Legal Status : A Public Company limited by shares registered under companies
Act, 1994 and listed with Dhaka Stock Exchange Limited and
Chittagong Stock Exchange Limited.

Date of Incorporation : C-65459(2951)/2007 dated: 25.01.2007

Converted into Public Limited Company : 07-May-2016

Commencement of Commercial Operation : 01-March -2013

Production Capacity : Bolus Products (in Pcs): 15.12 Million Pcs/Year
Powder Products (in Kg): 1.13 Million Kg/Year
Liquid Products (in Litre):1.32 Million Litre/Year

Registered Office & Factory : Plot # B 50-54 BSCIC Industrial Estate, Dhamrai, Dhaka

Corporate Office : Rupayan Karim Tower, Level # 10, 80, Kakrail, V.I.P. Road, Ramna,


Nature of Business :The Company is a Pharmaceutical company which is engaged in manufacturing, importing and marketing of animal health care drugs, nutritional supplements and feed additives for livestock like powder, bolus and liquid dosage forms.

Authorized Capital : BDT 1,000 million
Paid Up Capital : BDT 830.06 million
Date of Approval for IPO : January 11, 2018
Date of Listing with DSE : April 01, 2018
Date of Listing with CSE : March 28, 2018

Principal Bankers : Dutch Bangla Bank Ltd, Satmasjid Road Br, IFIC Bank Ltd, Dhanmondi Br,
Shahjalal Islami Bank Ltd, Satmasjid Road Br.
Midland Bank Ltd., Dilkusha Corporate Br.

External Auditors : Ahmed Zaker & Co., Chartered Accountants
Green City Edge (Level-10),89 Kakrail, Dhaka-1000.

Tax Consultants & Legal Advisor : Nasir Uddin Ahmed, M. Com (Mgt.), L.L.B
48 & 49 Kakrail, Sky View Mamta Center, A-2(2nd Floor),

Credit Rating Agency : Alpha Credit Rating Ltd.
Sadharan Bima Bhaban-2 (8th floor), 139 Motijheel C/A, Dhaka-1000.



Mr. Kauser BHUIYAN is a German educated Economist, former EU diplomat and Wall-Street professional who gained more than two decades of professional experience at Accenture, Bloomberg, European Commission and Stein & Partners. He learned professional skills in the areas of Change Management Consulting, International Financial Market, Economic Co-operation and Sustainability Advisory services in Frankfurt, Zurich, London, New York, Brussels, Islamabad, Dhaka and Bangkok. Mr. Bhuiyan can be reached at to [at]

Another $25m IFC loan to a Bangladeshi company PRAN


International Finance Corporation (IFC), the private sector development arm of the World Bank Group, has provided yet another $25 million loan […]

Korean Export Processing Zone at serious risk


Instead of handing over the Korean Export Processing Zone (KEPZ) to the investor, the government of Bangladesh plans to take back […]

Dhaka needs to remove its rocky anti-FDI atmosphere

Korean Ambassador to Bangladesh Lee Yun-young

Korean Ambassador to Bangladesh Mr. Lee Yun-young has said Bangladesh should come out from protectionism and open up its market […]

‘Welfare Associations’ to negotiate for rights at Bangladesh EPZ

The Government of Bangladesh today approved, in principle, draft of a labour law for Export Processing Zones (EPZ) with the provision […]

Return of GSP seems far off – a lot more must be done

Bangladesh’s progress in implementation of the National Tripartite Plan of Action on Fire Safety and Structural Integrity (the Action Plan) which provides a […]

Bangladesh halts shutdown of “unsafe” factories

The Bangladeshi government is refusing to shut down garment factories declared unsafe, following a row with independent inspectors over the […]